Aceto Names Dr. Lukas von Hippel Acting Managing Director at Pharma Waldhof

        Print
| Source: ACETO Corporation

PORT WASHINGTON, N.Y., July 1, 2011 (GLOBE NEWSWIRE) -- Aceto Corporation (Nasdaq:ACET), a global leader in the marketing and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals today announced that Dr. Lukas von Hippel has been named Acting Managing Director at its Pharma Waldhof operating subsidiary in Germany. Prior to Aceto, Dr. von Hippel began his professional career with the former German chemical group Degussa where he held various positions in R&D, business development and marketing and sales for more than 12 years, and later worked at AllessaChemie, the privately owned German fine and specialty chemicals company, most recently as a member of the managing board focused on marketing and sales. Dr. von Hippel holds a Master in Physical Chemistry from the Ludwig-Maximilians-University in Munich, Germany.

Commenting on the announcement, Albert Eilender, Chairman and CEO of Aceto, said, "Pharma Waldhof, which we acquired from Hoffmann-La Roche, has been a key component within our Health Science business segment. With the calendar year-end retirement of its founder and Managing Director, Ulf Bender, who is in his 37th year with Pharma Waldhof, 33 as Managing Director, we are extremely pleased to have Lukas join our organization. Lukas brings with him nearly 20 years of experience in the pharmaceutical and chemical industry developing, marketing and selling products with a major focus on fine chemicals and API's for the life sciences arena. As part of this transition, the management of Pharma Waldhof will report directly to Vincent Miata, President and COO. Furthermore, to ensure a smooth and seamless transition at Pharma Waldhof, following his retirement from full-time activities, Ulf will be a consultant to the Company and we will rely on him and his team to continue their significant contributions to our Pharma business."

ABOUT ACETO

Aceto Corporation, incorporated in 1947, is a global leader in the marketing and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals. With business operations in ten countries, Aceto distributes over 1,100 chemical compounds used principally as finished products or raw materials in the pharmaceutical, nutraceutical, agricultural, coatings and industrial chemical consuming industries. Aceto's global operations, including a staff of 26 in China and 12 in India, are distinctive in the industry and enable its worldwide sourcing and regulatory capabilities. (ACET-F)

Theodore Ayvas
Director of Corporate Communications
& Investor Relations
Aceto Corporation
(516) 627-6000
www.aceto.com